Promentis Pharmaceuticals Inc

Promentis Pharmaceuticals, Inc. develops biopharmaceutical therapies for neuropsychiatric and CNS disorders. The Company advances novel oral compounds targeting glutamatergic imbalances and oxidative stress, with a focus on psychiatric conditions such as trichotillomania. Promentis Pharmaceuticals Inc serves patients across the United States.